Abstract
Eight tridentate bipyrazole derivatives with different side arms have been prepared in one step and with good yields. The products were screened for their cytotoxic activity against three tumor cell lines—human breast cancer cell line MDA-MB231, human prostate cancer cell line PC3, and human colorectal cell line LoVo, by use of colorimetric MTT assay. Structure–activity relationships reflected the effect of substituted drugs. Among this series, two compounds had remarkable in-vitro antiproliferative activity against the LoVo cell line with IC50 values ranging from 2.6 to 2.7 μg ml−1. All the compounds had suitable drug-like characteristics according to Lipinski’s rule.
Similar content being viewed by others
References
A.K. Tewari, A. Mishra, Bioorg. Med. Chem. 9, 715 (2001)
J. Haufel, E. Breitmaier, Angew. Chem. 13, 604 (1974)
D.J. Wustrow, T. Capiris, R. Rubin, J.A. Knobelsdorf, H. Akunne, M.D. Davis, R. MacKenzie, T.A. Pugsley, K.T. Zoski, T.G. Heffner, L.D. Wise, Bioorg. Med. Chem. Lett. 8, 2067 (1998)
R.H. Wiley, P. Wiley, Pyrazolones, Pyrazolidones and Derivatives (Wiley, New York, 1964), p. 102
E.V. Pimerova, E.V. Voronina, Pharm. Chem. J. 35, 18 (2001)
S.L. Janus, A.Z. Magdif, B.P. Erik, N. Claus, Monatsh. Chem. 130, 1167 (1999)
H.J. Park, K. Lee, S. Park, B. Ahn, J.C. Lee, H.Y. Cho, K.I. Lee, Bioorg. Med. Chem. Lett. 15, 3307 (2005)
I. Bouabdallah, L.A. M’barek, A. Zyad, A. Ramadani, I. Zidane, A. Melhaoui, Nat. Prod. Res. 20, 1024 (2006)
V. Michon, C.H. Du Penhoat, F. Tombret, J.M. Gillardin, F. Lepage, L. Berthon, Eur. J. Med. Chem. 30, 147 (1995)
I. Yildirim, N. Ozdemir, Y. Akçamur, M. Dinçer, O. Andaç, Acta Cryst. E61, 256 (2005)
D.M. Bailey, P.E. Hansen, A.G. Hlavac, E.R. Baizman, J. Pearl, A.F. Defelice, M.E. Feigenson, J. Med. Chem. 28, 256 (1985)
K.L. Kees, J.J. Fitzgerald, K.E. Steiner, J.F. Mattes, B. Mihan, T. Tosi, D. Mondoro, M.L. McCaleb, J. Med. Chem. 39, 3920 (1996)
C.K. Chu, J. Cutler, J. Heterocycl Chem. 23, 289 (1986)
A.R. Katritzky, C.W. Rees, E.F.V. Scriven, in Comprehensive Heterocyclic Chemistry, ed. by T. Potts Kevin, vol 5 (Pergamon, Oxford, 1984), p. 291
S. Demirayak, A.C. Karaburum, R. Beis, Eur. J. Med. Chem. 39, 1089 (2004)
R. Silvestri, M.G. Cascio, G.L. Regina, F. Piscitelli, A. Lavecchia, A. Brizzi, S. Pasquini, M. Botta, E. Novellino, V.D. Marzo, F. Corelli, J. Med. Chem. 51, 1560 (2008)
S. Radi, Y. Toubi, N. Draoui, O. Feron, O. Riant, Lett. Drug Des. Discov. 9, 305 (2012)
S. Radi, Y. Toubi, I. Hamdani, A. Hakkou, F. Souna, I. Himri, M. Bouakka, Res. J. Chem. Sci. 2, 40 (2012)
S. Radi, S. Salhi, A. Radi, Lett. Drug Des. Discov. 7, 27 (2010)
A. Yahyi, A. Ettouhami, S. Radi, I. Zidane, A. Hakkou, M. Bouakka, Lett. Drug Des. Discov. 4, 382 (2007)
I.R. Evans, K.M. Szécsényi, V.M. Leovac, Acta Cryst. E61, 625 (2005)
W.L. Driessen, Recl. Trav. Chim. Pays-Bas 101, 441 (1982)
R. Huttel, P. Jochum, Chem. Ber. 85, 820 (1952)
I. Dvoretzky, G.H. Richter, J. Org. Chem. 15, 1285 (1950)
M. Daoudi, N. Ben Larbi, A. Kerbal, B. Bennani, J.-P. Launay, J. Bonvoisin, T. Ben Hadda, P.H. Dixneuf, Tetrahedron 62, 3123 (2006)
R. Touzani, A. Ramdani, T. Ben-Hadda, S. El Kadiri, O. Maury, H. Le Bozec, P.H. Dixneuf, Synth. Commun. 31, 1315 (2001)
A. Attayibat, R. Touzani, S. Radi, A. Ramdani, B. Hacht, S. El Kadiri, J. Mar. Chim. Heterocycl. 9, 15 (2010)
M. El Kodadi, F. Malek, R. Touzani, A. Ramdani, S. El Kadiri, D. Eddike, Molecules 8, 780 (2003)
M. El Ayyachy, M. El Kodadi, A. Aouinti, A. Ramdani, B. Hammouti, F. Malek, A. El Idrissi, Mater. Chem. Phys., 93, 281 (2005)
M. Elkodadi, M. Benamar, I. Bouabdellah, A. Zyad, F. Malek, R. Touzani, A. Ramdani, A. Melhaoui, Nat. Prod. Res. 21, 947 (2007)
T. Harit, M. Cherfi, J. Isaad, A. Riahi, F. Malek, Tetrahedron 68, 4037 (2012)
J.G. Topliss, J. Med. Chem. 15, 1006 (1972)
P. Ertl, J. Chem. Inf. Comput. Sci. 43, 374 (2003)
T.I. Oprea, A.M. Davis, S.J. Teague, P.D. Leeson, J. Chem. Inf. Comput. Sci. 41, 1308 (2001)
Acknowledgments
This work was supported by the CUD (Commission Universitaire pour le Développement, Belgium) within the framework of the P3 program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malek, F., Draoui, N., Feron, O. et al. Tridentate bipyrazole compounds with a side-arm as a new class of antitumor agents. Res Chem Intermed 40, 681–687 (2014). https://doi.org/10.1007/s11164-012-0993-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-012-0993-z